Global Human Coagulation Factor XIII Market Research Report 2026(Status and Outlook)
Human coagulation Factor XIII (Factor XIII, abbreviated as FXIII), also known as fibrinogen stabilizing factor, is the last coagulation factor in the coagulation cascade. It plays a crucial role in the coagulation process, primarily functioning to crosslink fibrinogen monomers into stable fibrin clots, thereby reinforcing the blood clot and preventing its premature dissolution. This is of great significance in maintaining normal hemostasis and coagulation function.
The global Human Coagulation Factor XIII market size was estimated at USD 89.6 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Human Coagulation Factor XIII market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Human Coagulation Factor XIII market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Human Coagulation Factor XIII market.
Global Human Coagulation Factor XIII Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL Behring
Merck KGaA
Invitrogen (Thermo Fisher Scientific Inc.)
ZEDIRA GmbH
Sino Biological, Inc.
Cell Sciences, Inc.
Enzyme Research Laboratories Inc.
Market Segmentation (by Type)
Lyophilized Powder
Liquid
Market Segmentation (by Application)
Surgery
Disease Treatment
Medical Research
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Coagulation Factor XIII Market
Overview of the regional outlook of the Human Coagulation Factor XIII Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Coagulation Factor XIII Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Coagulation Factor XIII, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Human Coagulation Factor XIII market size was estimated at USD 89.6 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Human Coagulation Factor XIII market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Human Coagulation Factor XIII market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Human Coagulation Factor XIII market.
Global Human Coagulation Factor XIII Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL Behring
Merck KGaA
Invitrogen (Thermo Fisher Scientific Inc.)
ZEDIRA GmbH
Sino Biological, Inc.
Cell Sciences, Inc.
Enzyme Research Laboratories Inc.
Market Segmentation (by Type)
Lyophilized Powder
Liquid
Market Segmentation (by Application)
Surgery
Disease Treatment
Medical Research
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Coagulation Factor XIII Market
Overview of the regional outlook of the Human Coagulation Factor XIII Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Coagulation Factor XIII Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Coagulation Factor XIII, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Coagulation Factor XIII
1.2 Key Market Segments
1.2.1 Human Coagulation Factor XIII Segment by Type
1.2.2 Human Coagulation Factor XIII Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN COAGULATION FACTOR XIII MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Coagulation Factor XIII Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Human Coagulation Factor XIII Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN COAGULATION FACTOR XIII MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Human Coagulation Factor XIII Product Life Cycle
3.3 Global Human Coagulation Factor XIII Sales by Manufacturers (2020-2025)
3.4 Global Human Coagulation Factor XIII Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Coagulation Factor XIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Coagulation Factor XIII Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Human Coagulation Factor XIII Market Competitive Situation and Trends
3.8.1 Human Coagulation Factor XIII Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Coagulation Factor XIII Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HUMAN COAGULATION FACTOR XIII INDUSTRY CHAIN ANALYSIS
4.1 Human Coagulation Factor XIII Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN COAGULATION FACTOR XIII MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Coagulation Factor XIII Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Human Coagulation Factor XIII Market
5.7 ESG Ratings of Leading Companies
6 HUMAN COAGULATION FACTOR XIII MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Coagulation Factor XIII Sales Market Share by Type (2020-2025)
6.3 Global Human Coagulation Factor XIII Market Size by Type (2020-2025)
6.4 Global Human Coagulation Factor XIII Price by Type (2020-2025)
7 HUMAN COAGULATION FACTOR XIII MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Coagulation Factor XIII Market Sales by Application (2020-2025)
7.3 Global Human Coagulation Factor XIII Market Size (M USD) by Application (2020-2025)
7.4 Global Human Coagulation Factor XIII Sales Growth Rate by Application (2020-2025)
8 HUMAN COAGULATION FACTOR XIII MARKET SALES BY REGION
8.1 Global Human Coagulation Factor XIII Sales by Region
8.1.1 Global Human Coagulation Factor XIII Sales by Region
8.1.2 Global Human Coagulation Factor XIII Sales Market Share by Region
8.2 Global Human Coagulation Factor XIII Market Size by Region
8.2.1 Global Human Coagulation Factor XIII Market Size by Region
8.2.2 Global Human Coagulation Factor XIII Market Size by Region
8.3 North America
8.3.1 North America Human Coagulation Factor XIII Sales by Country
8.3.2 North America Human Coagulation Factor XIII Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Human Coagulation Factor XIII Sales by Country
8.4.2 Europe Human Coagulation Factor XIII Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Human Coagulation Factor XIII Sales by Region
8.5.2 Asia Pacific Human Coagulation Factor XIII Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Human Coagulation Factor XIII Sales by Country
8.6.2 South America Human Coagulation Factor XIII Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Human Coagulation Factor XIII Sales by Region
8.7.2 Middle East and Africa Human Coagulation Factor XIII Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HUMAN COAGULATION FACTOR XIII MARKET PRODUCTION BY REGION
9.1 Global Production of Human Coagulation Factor XIII by Region(2020-2025)
9.2 Global Human Coagulation Factor XIII Revenue Market Share by Region (2020-2025)
9.3 Global Human Coagulation Factor XIII Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Human Coagulation Factor XIII Production
9.4.1 North America Human Coagulation Factor XIII Production Growth Rate (2020-2025)
9.4.2 North America Human Coagulation Factor XIII Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Human Coagulation Factor XIII Production
9.5.1 Europe Human Coagulation Factor XIII Production Growth Rate (2020-2025)
9.5.2 Europe Human Coagulation Factor XIII Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Human Coagulation Factor XIII Production (2020-2025)
9.6.1 Japan Human Coagulation Factor XIII Production Growth Rate (2020-2025)
9.6.2 Japan Human Coagulation Factor XIII Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Human Coagulation Factor XIII Production (2020-2025)
9.7.1 China Human Coagulation Factor XIII Production Growth Rate (2020-2025)
9.7.2 China Human Coagulation Factor XIII Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL Behring
10.1.1 CSL Behring Basic Information
10.1.2 CSL Behring Human Coagulation Factor XIII Product Overview
10.1.3 CSL Behring Human Coagulation Factor XIII Product Market Performance
10.1.4 CSL Behring Business Overview
10.1.5 CSL Behring SWOT Analysis
10.1.6 CSL Behring Recent Developments
10.2 Merck KGaA
10.2.1 Merck KGaA Basic Information
10.2.2 Merck KGaA Human Coagulation Factor XIII Product Overview
10.2.3 Merck KGaA Human Coagulation Factor XIII Product Market Performance
10.2.4 Merck KGaA Business Overview
10.2.5 Merck KGaA SWOT Analysis
10.2.6 Merck KGaA Recent Developments
10.3 Invitrogen (Thermo Fisher Scientific Inc.)
10.3.1 Invitrogen (Thermo Fisher Scientific Inc.) Basic Information
10.3.2 Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Product Overview
10.3.3 Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Product Market Performance
10.3.4 Invitrogen (Thermo Fisher Scientific Inc.) Business Overview
10.3.5 Invitrogen (Thermo Fisher Scientific Inc.) SWOT Analysis
10.3.6 Invitrogen (Thermo Fisher Scientific Inc.) Recent Developments
10.4 ZEDIRA GmbH
10.4.1 ZEDIRA GmbH Basic Information
10.4.2 ZEDIRA GmbH Human Coagulation Factor XIII Product Overview
10.4.3 ZEDIRA GmbH Human Coagulation Factor XIII Product Market Performance
10.4.4 ZEDIRA GmbH Business Overview
10.4.5 ZEDIRA GmbH Recent Developments
10.5 Sino Biological, Inc.
10.5.1 Sino Biological, Inc. Basic Information
10.5.2 Sino Biological, Inc. Human Coagulation Factor XIII Product Overview
10.5.3 Sino Biological, Inc. Human Coagulation Factor XIII Product Market Performance
10.5.4 Sino Biological, Inc. Business Overview
10.5.5 Sino Biological, Inc. Recent Developments
10.6 Cell Sciences, Inc.
10.6.1 Cell Sciences, Inc. Basic Information
10.6.2 Cell Sciences, Inc. Human Coagulation Factor XIII Product Overview
10.6.3 Cell Sciences, Inc. Human Coagulation Factor XIII Product Market Performance
10.6.4 Cell Sciences, Inc. Business Overview
10.6.5 Cell Sciences, Inc. Recent Developments
10.7 Enzyme Research Laboratories Inc.
10.7.1 Enzyme Research Laboratories Inc. Basic Information
10.7.2 Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Product Overview
10.7.3 Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Product Market Performance
10.7.4 Enzyme Research Laboratories Inc. Business Overview
10.7.5 Enzyme Research Laboratories Inc. Recent Developments
11 HUMAN COAGULATION FACTOR XIII MARKET FORECAST BY REGION
11.1 Global Human Coagulation Factor XIII Market Size Forecast
11.2 Global Human Coagulation Factor XIII Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Coagulation Factor XIII Market Size Forecast by Country
11.2.3 Asia Pacific Human Coagulation Factor XIII Market Size Forecast by Region
11.2.4 South America Human Coagulation Factor XIII Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Human Coagulation Factor XIII by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Human Coagulation Factor XIII Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Human Coagulation Factor XIII by Type (2026-2035)
12.1.2 Global Human Coagulation Factor XIII Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Human Coagulation Factor XIII by Type (2026-2035)
12.2 Global Human Coagulation Factor XIII Market Forecast by Application (2026-2035)
12.2.1 Global Human Coagulation Factor XIII Sales (K MT) Forecast by Application
12.2.2 Global Human Coagulation Factor XIII Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Coagulation Factor XIII
1.2 Key Market Segments
1.2.1 Human Coagulation Factor XIII Segment by Type
1.2.2 Human Coagulation Factor XIII Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN COAGULATION FACTOR XIII MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Coagulation Factor XIII Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Human Coagulation Factor XIII Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN COAGULATION FACTOR XIII MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Human Coagulation Factor XIII Product Life Cycle
3.3 Global Human Coagulation Factor XIII Sales by Manufacturers (2020-2025)
3.4 Global Human Coagulation Factor XIII Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Coagulation Factor XIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Coagulation Factor XIII Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Human Coagulation Factor XIII Market Competitive Situation and Trends
3.8.1 Human Coagulation Factor XIII Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Coagulation Factor XIII Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HUMAN COAGULATION FACTOR XIII INDUSTRY CHAIN ANALYSIS
4.1 Human Coagulation Factor XIII Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN COAGULATION FACTOR XIII MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Coagulation Factor XIII Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Human Coagulation Factor XIII Market
5.7 ESG Ratings of Leading Companies
6 HUMAN COAGULATION FACTOR XIII MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Coagulation Factor XIII Sales Market Share by Type (2020-2025)
6.3 Global Human Coagulation Factor XIII Market Size by Type (2020-2025)
6.4 Global Human Coagulation Factor XIII Price by Type (2020-2025)
7 HUMAN COAGULATION FACTOR XIII MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Coagulation Factor XIII Market Sales by Application (2020-2025)
7.3 Global Human Coagulation Factor XIII Market Size (M USD) by Application (2020-2025)
7.4 Global Human Coagulation Factor XIII Sales Growth Rate by Application (2020-2025)
8 HUMAN COAGULATION FACTOR XIII MARKET SALES BY REGION
8.1 Global Human Coagulation Factor XIII Sales by Region
8.1.1 Global Human Coagulation Factor XIII Sales by Region
8.1.2 Global Human Coagulation Factor XIII Sales Market Share by Region
8.2 Global Human Coagulation Factor XIII Market Size by Region
8.2.1 Global Human Coagulation Factor XIII Market Size by Region
8.2.2 Global Human Coagulation Factor XIII Market Size by Region
8.3 North America
8.3.1 North America Human Coagulation Factor XIII Sales by Country
8.3.2 North America Human Coagulation Factor XIII Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Human Coagulation Factor XIII Sales by Country
8.4.2 Europe Human Coagulation Factor XIII Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Human Coagulation Factor XIII Sales by Region
8.5.2 Asia Pacific Human Coagulation Factor XIII Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Human Coagulation Factor XIII Sales by Country
8.6.2 South America Human Coagulation Factor XIII Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Human Coagulation Factor XIII Sales by Region
8.7.2 Middle East and Africa Human Coagulation Factor XIII Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HUMAN COAGULATION FACTOR XIII MARKET PRODUCTION BY REGION
9.1 Global Production of Human Coagulation Factor XIII by Region(2020-2025)
9.2 Global Human Coagulation Factor XIII Revenue Market Share by Region (2020-2025)
9.3 Global Human Coagulation Factor XIII Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Human Coagulation Factor XIII Production
9.4.1 North America Human Coagulation Factor XIII Production Growth Rate (2020-2025)
9.4.2 North America Human Coagulation Factor XIII Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Human Coagulation Factor XIII Production
9.5.1 Europe Human Coagulation Factor XIII Production Growth Rate (2020-2025)
9.5.2 Europe Human Coagulation Factor XIII Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Human Coagulation Factor XIII Production (2020-2025)
9.6.1 Japan Human Coagulation Factor XIII Production Growth Rate (2020-2025)
9.6.2 Japan Human Coagulation Factor XIII Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Human Coagulation Factor XIII Production (2020-2025)
9.7.1 China Human Coagulation Factor XIII Production Growth Rate (2020-2025)
9.7.2 China Human Coagulation Factor XIII Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL Behring
10.1.1 CSL Behring Basic Information
10.1.2 CSL Behring Human Coagulation Factor XIII Product Overview
10.1.3 CSL Behring Human Coagulation Factor XIII Product Market Performance
10.1.4 CSL Behring Business Overview
10.1.5 CSL Behring SWOT Analysis
10.1.6 CSL Behring Recent Developments
10.2 Merck KGaA
10.2.1 Merck KGaA Basic Information
10.2.2 Merck KGaA Human Coagulation Factor XIII Product Overview
10.2.3 Merck KGaA Human Coagulation Factor XIII Product Market Performance
10.2.4 Merck KGaA Business Overview
10.2.5 Merck KGaA SWOT Analysis
10.2.6 Merck KGaA Recent Developments
10.3 Invitrogen (Thermo Fisher Scientific Inc.)
10.3.1 Invitrogen (Thermo Fisher Scientific Inc.) Basic Information
10.3.2 Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Product Overview
10.3.3 Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Product Market Performance
10.3.4 Invitrogen (Thermo Fisher Scientific Inc.) Business Overview
10.3.5 Invitrogen (Thermo Fisher Scientific Inc.) SWOT Analysis
10.3.6 Invitrogen (Thermo Fisher Scientific Inc.) Recent Developments
10.4 ZEDIRA GmbH
10.4.1 ZEDIRA GmbH Basic Information
10.4.2 ZEDIRA GmbH Human Coagulation Factor XIII Product Overview
10.4.3 ZEDIRA GmbH Human Coagulation Factor XIII Product Market Performance
10.4.4 ZEDIRA GmbH Business Overview
10.4.5 ZEDIRA GmbH Recent Developments
10.5 Sino Biological, Inc.
10.5.1 Sino Biological, Inc. Basic Information
10.5.2 Sino Biological, Inc. Human Coagulation Factor XIII Product Overview
10.5.3 Sino Biological, Inc. Human Coagulation Factor XIII Product Market Performance
10.5.4 Sino Biological, Inc. Business Overview
10.5.5 Sino Biological, Inc. Recent Developments
10.6 Cell Sciences, Inc.
10.6.1 Cell Sciences, Inc. Basic Information
10.6.2 Cell Sciences, Inc. Human Coagulation Factor XIII Product Overview
10.6.3 Cell Sciences, Inc. Human Coagulation Factor XIII Product Market Performance
10.6.4 Cell Sciences, Inc. Business Overview
10.6.5 Cell Sciences, Inc. Recent Developments
10.7 Enzyme Research Laboratories Inc.
10.7.1 Enzyme Research Laboratories Inc. Basic Information
10.7.2 Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Product Overview
10.7.3 Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Product Market Performance
10.7.4 Enzyme Research Laboratories Inc. Business Overview
10.7.5 Enzyme Research Laboratories Inc. Recent Developments
11 HUMAN COAGULATION FACTOR XIII MARKET FORECAST BY REGION
11.1 Global Human Coagulation Factor XIII Market Size Forecast
11.2 Global Human Coagulation Factor XIII Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Coagulation Factor XIII Market Size Forecast by Country
11.2.3 Asia Pacific Human Coagulation Factor XIII Market Size Forecast by Region
11.2.4 South America Human Coagulation Factor XIII Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Human Coagulation Factor XIII by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Human Coagulation Factor XIII Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Human Coagulation Factor XIII by Type (2026-2035)
12.1.2 Global Human Coagulation Factor XIII Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Human Coagulation Factor XIII by Type (2026-2035)
12.2 Global Human Coagulation Factor XIII Market Forecast by Application (2026-2035)
12.2.1 Global Human Coagulation Factor XIII Sales (K MT) Forecast by Application
12.2.2 Global Human Coagulation Factor XIII Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Human Coagulation Factor XIII Market Size by Type (M USD)
Table 4. Global Human Coagulation Factor XIII Market Size by Application
Table 5. Human Coagulation Factor XIII Market Size Comparison by Region (M USD)
Table 6. Global Human Coagulation Factor XIII Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Human Coagulation Factor XIII Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Human Coagulation Factor XIII Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Human Coagulation Factor XIII Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor XIII as of 2025)
Table 11. Global Market Human Coagulation Factor XIII Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Human Coagulation Factor XIII Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Coagulation Factor XIII Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Human Coagulation Factor XIII Sales by Type (K MT)
Table 27. Global Human Coagulation Factor XIII Market Size by Type (M USD)
Table 28. Global Human Coagulation Factor XIII Sales (K MT) by Type (2020-2025)
Table 29. Global Human Coagulation Factor XIII Sales Market Share by Type (2020-2025)
Table 30. Global Human Coagulation Factor XIII Market Size (M USD) by Type (2020-2025)
Table 31. Global Human Coagulation Factor XIII Market Share by Type (2020-2025)
Table 32. Global Human Coagulation Factor XIII Price (USD/KG) by Type (2020-2025)
Table 33. Global Human Coagulation Factor XIII Sales (K MT) by Application
Table 34. Global Human Coagulation Factor XIII Market Size by Application
Table 35. Global Human Coagulation Factor XIII Sales by Application (2020-2025) & (K MT)
Table 36. Global Human Coagulation Factor XIII Sales Market Share by Application (2020-2025)
Table 37. Global Human Coagulation Factor XIII Market Size by Application (2020-2025) & (M USD)
Table 38. Global Human Coagulation Factor XIII Market Share by Application (2020-2025)
Table 39. Global Human Coagulation Factor XIII Sales Growth Rate by Application (2020-2025)
Table 40. Global Human Coagulation Factor XIII Sales by Region (2020-2025) & (K MT)
Table 41. Global Human Coagulation Factor XIII Sales Market Share by Region (2020-2025)
Table 42. Global Human Coagulation Factor XIII Market Size by Region (2020-2025) & (M USD)
Table 43. Global Human Coagulation Factor XIII Market Size by Region (2020-2025)
Table 44. North America Human Coagulation Factor XIII Sales by Country (2020-2025) & (K MT)
Table 45. North America Human Coagulation Factor XIII Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Human Coagulation Factor XIII Sales by Country (2020-2025) & (K MT)
Table 47. Europe Human Coagulation Factor XIII Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Human Coagulation Factor XIII Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Human Coagulation Factor XIII Market Size by Region (2020-2025) & (M USD)
Table 50. South America Human Coagulation Factor XIII Sales by Country (2020-2025) & (K MT)
Table 51. South America Human Coagulation Factor XIII Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Human Coagulation Factor XIII Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Human Coagulation Factor XIII Market Size by Region (2020-2025) & (M USD)
Table 54. Global Human Coagulation Factor XIII Production (K MT) by Region(2020-2025)
Table 55. Global Human Coagulation Factor XIII Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Human Coagulation Factor XIII Revenue Market Share by Region (2020-2025)
Table 57. Global Human Coagulation Factor XIII Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Human Coagulation Factor XIII Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Human Coagulation Factor XIII Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Human Coagulation Factor XIII Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Human Coagulation Factor XIII Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. CSL Behring Basic Information
Table 63. CSL Behring Human Coagulation Factor XIII Product Overview
Table 64. CSL Behring Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. CSL Behring Business Overview
Table 66. CSL Behring SWOT Analysis
Table 67. CSL Behring Recent Developments
Table 68. Merck KGaA Basic Information
Table 69. Merck KGaA Human Coagulation Factor XIII Product Overview
Table 70. Merck KGaA Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck KGaA Business Overview
Table 72. Merck KGaA SWOT Analysis
Table 73. Merck KGaA Recent Developments
Table 74. Invitrogen (Thermo Fisher Scientific Inc.) Basic Information
Table 75. Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Product Overview
Table 76. Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Invitrogen (Thermo Fisher Scientific Inc.) Business Overview
Table 78. Invitrogen (Thermo Fisher Scientific Inc.) SWOT Analysis
Table 79. Invitrogen (Thermo Fisher Scientific Inc.) Recent Developments
Table 80. ZEDIRA GmbH Basic Information
Table 81. ZEDIRA GmbH Human Coagulation Factor XIII Product Overview
Table 82. ZEDIRA GmbH Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. ZEDIRA GmbH Business Overview
Table 84. ZEDIRA GmbH Recent Developments
Table 85. Sino Biological, Inc. Basic Information
Table 86. Sino Biological, Inc. Human Coagulation Factor XIII Product Overview
Table 87. Sino Biological, Inc. Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Sino Biological, Inc. Business Overview
Table 89. Sino Biological, Inc. Recent Developments
Table 90. Cell Sciences, Inc. Basic Information
Table 91. Cell Sciences, Inc. Human Coagulation Factor XIII Product Overview
Table 92. Cell Sciences, Inc. Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Cell Sciences, Inc. Business Overview
Table 94. Cell Sciences, Inc. Recent Developments
Table 95. Enzyme Research Laboratories Inc. Basic Information
Table 96. Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Product Overview
Table 97. Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Enzyme Research Laboratories Inc. Business Overview
Table 99. Enzyme Research Laboratories Inc. Recent Developments
Table 100. Global Human Coagulation Factor XIII Sales Forecast by Region (2026-2035) & (K MT)
Table 101. Global Human Coagulation Factor XIII Market Size Forecast by Region (2026-2035) & (M USD)
Table 102. North America Human Coagulation Factor XIII Sales Forecast by Country (2026-2035) & (K MT)
Table 103. North America Human Coagulation Factor XIII Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Europe Human Coagulation Factor XIII Sales Forecast by Country (2026-2035) & (K MT)
Table 105. Europe Human Coagulation Factor XIII Market Size Forecast by Country (2026-2035) & (M USD)
Table 106. Asia Pacific Human Coagulation Factor XIII Sales Forecast by Region (2026-2035) & (K MT)
Table 107. Asia Pacific Human Coagulation Factor XIII Market Size Forecast by Region (2026-2035) & (M USD)
Table 108. South America Human Coagulation Factor XIII Sales Forecast by Country (2026-2035) & (K MT)
Table 109. South America Human Coagulation Factor XIII Market Size Forecast by Country (2026-2035) & (M USD)
Table 110. Middle East and Africa Human Coagulation Factor XIII Sales Forecast by Country (2026-2035) & (Units)
Table 111. Middle East and Africa Human Coagulation Factor XIII Market Size Forecast by Country (2026-2035) & (M USD)
Table 112. Global Human Coagulation Factor XIII Sales Forecast by Type (2026-2035) & (K MT)
Table 113. Global Human Coagulation Factor XIII Market Size Forecast by Type (2026-2035) & (M USD)
Table 114. Global Human Coagulation Factor XIII Price Forecast by Type (2026-2035) & (USD/KG)
Table 115. Global Human Coagulation Factor XIII Sales (K MT) Forecast by Application (2026-2035)
Table 116. Global Human Coagulation Factor XIII Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Human Coagulation Factor XIII Market Size by Type (M USD)
Table 4. Global Human Coagulation Factor XIII Market Size by Application
Table 5. Human Coagulation Factor XIII Market Size Comparison by Region (M USD)
Table 6. Global Human Coagulation Factor XIII Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Human Coagulation Factor XIII Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Human Coagulation Factor XIII Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Human Coagulation Factor XIII Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor XIII as of 2025)
Table 11. Global Market Human Coagulation Factor XIII Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Human Coagulation Factor XIII Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Coagulation Factor XIII Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Human Coagulation Factor XIII Sales by Type (K MT)
Table 27. Global Human Coagulation Factor XIII Market Size by Type (M USD)
Table 28. Global Human Coagulation Factor XIII Sales (K MT) by Type (2020-2025)
Table 29. Global Human Coagulation Factor XIII Sales Market Share by Type (2020-2025)
Table 30. Global Human Coagulation Factor XIII Market Size (M USD) by Type (2020-2025)
Table 31. Global Human Coagulation Factor XIII Market Share by Type (2020-2025)
Table 32. Global Human Coagulation Factor XIII Price (USD/KG) by Type (2020-2025)
Table 33. Global Human Coagulation Factor XIII Sales (K MT) by Application
Table 34. Global Human Coagulation Factor XIII Market Size by Application
Table 35. Global Human Coagulation Factor XIII Sales by Application (2020-2025) & (K MT)
Table 36. Global Human Coagulation Factor XIII Sales Market Share by Application (2020-2025)
Table 37. Global Human Coagulation Factor XIII Market Size by Application (2020-2025) & (M USD)
Table 38. Global Human Coagulation Factor XIII Market Share by Application (2020-2025)
Table 39. Global Human Coagulation Factor XIII Sales Growth Rate by Application (2020-2025)
Table 40. Global Human Coagulation Factor XIII Sales by Region (2020-2025) & (K MT)
Table 41. Global Human Coagulation Factor XIII Sales Market Share by Region (2020-2025)
Table 42. Global Human Coagulation Factor XIII Market Size by Region (2020-2025) & (M USD)
Table 43. Global Human Coagulation Factor XIII Market Size by Region (2020-2025)
Table 44. North America Human Coagulation Factor XIII Sales by Country (2020-2025) & (K MT)
Table 45. North America Human Coagulation Factor XIII Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Human Coagulation Factor XIII Sales by Country (2020-2025) & (K MT)
Table 47. Europe Human Coagulation Factor XIII Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Human Coagulation Factor XIII Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Human Coagulation Factor XIII Market Size by Region (2020-2025) & (M USD)
Table 50. South America Human Coagulation Factor XIII Sales by Country (2020-2025) & (K MT)
Table 51. South America Human Coagulation Factor XIII Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Human Coagulation Factor XIII Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Human Coagulation Factor XIII Market Size by Region (2020-2025) & (M USD)
Table 54. Global Human Coagulation Factor XIII Production (K MT) by Region(2020-2025)
Table 55. Global Human Coagulation Factor XIII Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Human Coagulation Factor XIII Revenue Market Share by Region (2020-2025)
Table 57. Global Human Coagulation Factor XIII Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Human Coagulation Factor XIII Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Human Coagulation Factor XIII Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Human Coagulation Factor XIII Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Human Coagulation Factor XIII Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. CSL Behring Basic Information
Table 63. CSL Behring Human Coagulation Factor XIII Product Overview
Table 64. CSL Behring Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. CSL Behring Business Overview
Table 66. CSL Behring SWOT Analysis
Table 67. CSL Behring Recent Developments
Table 68. Merck KGaA Basic Information
Table 69. Merck KGaA Human Coagulation Factor XIII Product Overview
Table 70. Merck KGaA Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck KGaA Business Overview
Table 72. Merck KGaA SWOT Analysis
Table 73. Merck KGaA Recent Developments
Table 74. Invitrogen (Thermo Fisher Scientific Inc.) Basic Information
Table 75. Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Product Overview
Table 76. Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Invitrogen (Thermo Fisher Scientific Inc.) Business Overview
Table 78. Invitrogen (Thermo Fisher Scientific Inc.) SWOT Analysis
Table 79. Invitrogen (Thermo Fisher Scientific Inc.) Recent Developments
Table 80. ZEDIRA GmbH Basic Information
Table 81. ZEDIRA GmbH Human Coagulation Factor XIII Product Overview
Table 82. ZEDIRA GmbH Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. ZEDIRA GmbH Business Overview
Table 84. ZEDIRA GmbH Recent Developments
Table 85. Sino Biological, Inc. Basic Information
Table 86. Sino Biological, Inc. Human Coagulation Factor XIII Product Overview
Table 87. Sino Biological, Inc. Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Sino Biological, Inc. Business Overview
Table 89. Sino Biological, Inc. Recent Developments
Table 90. Cell Sciences, Inc. Basic Information
Table 91. Cell Sciences, Inc. Human Coagulation Factor XIII Product Overview
Table 92. Cell Sciences, Inc. Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Cell Sciences, Inc. Business Overview
Table 94. Cell Sciences, Inc. Recent Developments
Table 95. Enzyme Research Laboratories Inc. Basic Information
Table 96. Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Product Overview
Table 97. Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Enzyme Research Laboratories Inc. Business Overview
Table 99. Enzyme Research Laboratories Inc. Recent Developments
Table 100. Global Human Coagulation Factor XIII Sales Forecast by Region (2026-2035) & (K MT)
Table 101. Global Human Coagulation Factor XIII Market Size Forecast by Region (2026-2035) & (M USD)
Table 102. North America Human Coagulation Factor XIII Sales Forecast by Country (2026-2035) & (K MT)
Table 103. North America Human Coagulation Factor XIII Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Europe Human Coagulation Factor XIII Sales Forecast by Country (2026-2035) & (K MT)
Table 105. Europe Human Coagulation Factor XIII Market Size Forecast by Country (2026-2035) & (M USD)
Table 106. Asia Pacific Human Coagulation Factor XIII Sales Forecast by Region (2026-2035) & (K MT)
Table 107. Asia Pacific Human Coagulation Factor XIII Market Size Forecast by Region (2026-2035) & (M USD)
Table 108. South America Human Coagulation Factor XIII Sales Forecast by Country (2026-2035) & (K MT)
Table 109. South America Human Coagulation Factor XIII Market Size Forecast by Country (2026-2035) & (M USD)
Table 110. Middle East and Africa Human Coagulation Factor XIII Sales Forecast by Country (2026-2035) & (Units)
Table 111. Middle East and Africa Human Coagulation Factor XIII Market Size Forecast by Country (2026-2035) & (M USD)
Table 112. Global Human Coagulation Factor XIII Sales Forecast by Type (2026-2035) & (K MT)
Table 113. Global Human Coagulation Factor XIII Market Size Forecast by Type (2026-2035) & (M USD)
Table 114. Global Human Coagulation Factor XIII Price Forecast by Type (2026-2035) & (USD/KG)
Table 115. Global Human Coagulation Factor XIII Sales (K MT) Forecast by Application (2026-2035)
Table 116. Global Human Coagulation Factor XIII Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Coagulation Factor XIII
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Coagulation Factor XIII Market Size (M USD), 2025-2035
Figure 5. Global Human Coagulation Factor XIII Market Size (M USD) (2020-2035)
Figure 6. Global Human Coagulation Factor XIII Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Coagulation Factor XIII Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Coagulation Factor XIII Product Life Cycle
Figure 13. Human Coagulation Factor XIII Sales Share by Manufacturers in 2025
Figure 14. Global Human Coagulation Factor XIII Revenue Share by Manufacturers in 2025
Figure 15. Human Coagulation Factor XIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Human Coagulation Factor XIII Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Coagulation Factor XIII Revenue in 2025
Figure 18. Industry Chain Map of Human Coagulation Factor XIII
Figure 19. Global Human Coagulation Factor XIII Market PEST Analysis
Figure 20. Global Human Coagulation Factor XIII Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Human Coagulation Factor XIII Market Share by Type
Figure 27. Sales Market Share of Human Coagulation Factor XIII by Type (2020-2025)
Figure 28. Sales Market Share of Human Coagulation Factor XIII by Type in 2025
Figure 29. Market Share of Human Coagulation Factor XIII by Type (2020-2025)
Figure 30. Market Share of Human Coagulation Factor XIII by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Human Coagulation Factor XIII Market Share by Application
Figure 33. Global Human Coagulation Factor XIII Sales Market Share by Application (2020-2025)
Figure 34. Global Human Coagulation Factor XIII Sales Market Share by Application in 2025
Figure 35. Global Human Coagulation Factor XIII Market Share by Application (2020-2025)
Figure 36. Global Human Coagulation Factor XIII Market Share by Application in 2025
Figure 37. Global Human Coagulation Factor XIII Sales Growth Rate by Application (2020-2025)
Figure 38. Global Human Coagulation Factor XIII Sales Market Share by Region (2020-2025)
Figure 39. Global Human Coagulation Factor XIII Market Size by Region (2020-2025)
Figure 40. North America Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Human Coagulation Factor XIII Sales Market Share by Country in 2024
Figure 43. North America Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Human Coagulation Factor XIII Market Size by Country in 2024
Figure 45. U.S. Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Human Coagulation Factor XIII Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Human Coagulation Factor XIII Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Human Coagulation Factor XIII Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Human Coagulation Factor XIII Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Human Coagulation Factor XIII Sales Market Share by Country in 2024
Figure 53. Europe Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Human Coagulation Factor XIII Market Size by Country in 2024
Figure 55. Germany Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Human Coagulation Factor XIII Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Human Coagulation Factor XIII Sales Market Share by Region in 2024
Figure 67. Asia Pacific Human Coagulation Factor XIII Market Size by Region in 2024
Figure 68. China Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Human Coagulation Factor XIII Sales and Growth Rate (K MT)
Figure 79. South America Human Coagulation Factor XIII Sales Market Share by Country in 2024
Figure 80. South America Human Coagulation Factor XIII Market Size and Growth Rate (M USD)
Figure 81. South America Human Coagulation Factor XIII Market Size by Country in 2024
Figure 82. Brazil Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Human Coagulation Factor XIII Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Human Coagulation Factor XIII Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Human Coagulation Factor XIII Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Human Coagulation Factor XIII Market Size by Region in 2024
Figure 92. Saudi Arabia Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Human Coagulation Factor XIII Production Market Share by Region (2020-2025)
Figure 103. North America Human Coagulation Factor XIII Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Human Coagulation Factor XIII Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Human Coagulation Factor XIII Production (K MT) Growth Rate (2020-2025)
Figure 106. China Human Coagulation Factor XIII Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Human Coagulation Factor XIII Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Human Coagulation Factor XIII Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Human Coagulation Factor XIII Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Human Coagulation Factor XIII Market Share Forecast by Type (2026-2035)
Figure 111. Global Human Coagulation Factor XIII Sales Forecast by Application (2026-2035)
Figure 112. Global Human Coagulation Factor XIII Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Human Coagulation Factor XIII
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Coagulation Factor XIII Market Size (M USD), 2025-2035
Figure 5. Global Human Coagulation Factor XIII Market Size (M USD) (2020-2035)
Figure 6. Global Human Coagulation Factor XIII Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Coagulation Factor XIII Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Coagulation Factor XIII Product Life Cycle
Figure 13. Human Coagulation Factor XIII Sales Share by Manufacturers in 2025
Figure 14. Global Human Coagulation Factor XIII Revenue Share by Manufacturers in 2025
Figure 15. Human Coagulation Factor XIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Human Coagulation Factor XIII Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Coagulation Factor XIII Revenue in 2025
Figure 18. Industry Chain Map of Human Coagulation Factor XIII
Figure 19. Global Human Coagulation Factor XIII Market PEST Analysis
Figure 20. Global Human Coagulation Factor XIII Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Human Coagulation Factor XIII Market Share by Type
Figure 27. Sales Market Share of Human Coagulation Factor XIII by Type (2020-2025)
Figure 28. Sales Market Share of Human Coagulation Factor XIII by Type in 2025
Figure 29. Market Share of Human Coagulation Factor XIII by Type (2020-2025)
Figure 30. Market Share of Human Coagulation Factor XIII by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Human Coagulation Factor XIII Market Share by Application
Figure 33. Global Human Coagulation Factor XIII Sales Market Share by Application (2020-2025)
Figure 34. Global Human Coagulation Factor XIII Sales Market Share by Application in 2025
Figure 35. Global Human Coagulation Factor XIII Market Share by Application (2020-2025)
Figure 36. Global Human Coagulation Factor XIII Market Share by Application in 2025
Figure 37. Global Human Coagulation Factor XIII Sales Growth Rate by Application (2020-2025)
Figure 38. Global Human Coagulation Factor XIII Sales Market Share by Region (2020-2025)
Figure 39. Global Human Coagulation Factor XIII Market Size by Region (2020-2025)
Figure 40. North America Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Human Coagulation Factor XIII Sales Market Share by Country in 2024
Figure 43. North America Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Human Coagulation Factor XIII Market Size by Country in 2024
Figure 45. U.S. Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Human Coagulation Factor XIII Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Human Coagulation Factor XIII Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Human Coagulation Factor XIII Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Human Coagulation Factor XIII Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Human Coagulation Factor XIII Sales Market Share by Country in 2024
Figure 53. Europe Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Human Coagulation Factor XIII Market Size by Country in 2024
Figure 55. Germany Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Human Coagulation Factor XIII Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Human Coagulation Factor XIII Sales Market Share by Region in 2024
Figure 67. Asia Pacific Human Coagulation Factor XIII Market Size by Region in 2024
Figure 68. China Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Human Coagulation Factor XIII Sales and Growth Rate (K MT)
Figure 79. South America Human Coagulation Factor XIII Sales Market Share by Country in 2024
Figure 80. South America Human Coagulation Factor XIII Market Size and Growth Rate (M USD)
Figure 81. South America Human Coagulation Factor XIII Market Size by Country in 2024
Figure 82. Brazil Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Human Coagulation Factor XIII Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Human Coagulation Factor XIII Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Human Coagulation Factor XIII Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Human Coagulation Factor XIII Market Size by Region in 2024
Figure 92. Saudi Arabia Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Human Coagulation Factor XIII Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Human Coagulation Factor XIII Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Human Coagulation Factor XIII Production Market Share by Region (2020-2025)
Figure 103. North America Human Coagulation Factor XIII Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Human Coagulation Factor XIII Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Human Coagulation Factor XIII Production (K MT) Growth Rate (2020-2025)
Figure 106. China Human Coagulation Factor XIII Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Human Coagulation Factor XIII Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Human Coagulation Factor XIII Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Human Coagulation Factor XIII Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Human Coagulation Factor XIII Market Share Forecast by Type (2026-2035)
Figure 111. Global Human Coagulation Factor XIII Sales Forecast by Application (2026-2035)
Figure 112. Global Human Coagulation Factor XIII Market Share Forecast by Application (2026-2035)
